Avobis Bio Reveals New Insights from STOMP2 Study at ECCO Congress Avobis Bio presented updated results from the STOMP2 clinical trial at the ECCO Congress, showing promising outcomes for Crohn's disease treatments.

Avobis Bio Reveals New Insights from STOMP2 Study at ECCO Congress #USA #Newark #Avobis_Bio #AVB-114 #STOMP2